Latest From Cigna Corp.
Former US FDA commissioner Scott Gottlieb makes a case for regional or national risk pools to ensure pediatric patients get timely access to gene therapy like the upcoming treatments for sickle cell disease.
Annual large employer health benefits survey for 2020 and beyond finds support for government price negotiation and payment through a national fund. Plans to expand point-of-sale rebates and coupon accumulator programs also reported.
AAM, Upsher-Smith, APhA, and Cigna tell US FDA that packaging requirement will increase manufacturing and drug costs, create reimbursement hurdles and reduce access to medicines. Daiichi-Sankyo supports agency's proposal.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Cigna Corp.
- Senior Management
David Cordani, Pres. & CEO
Eric Palmer, EVP & CFO
Alan Muney, MD, CMO, EVP, Total Health & Network
- Contact Info
Phone: (860) 226-6000
900 Cottage Grove Rd.
Bloomfield, CT 06002
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.